LINC01370

Across TCGA pan-cancer cohorts, LINC01370 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC01370’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where LINC01370 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01370 is over-expressed in tumor, although a few such as LIHC and STAD show the opposite, repressed pattern.

LIHC, STAD, and CHOL are the cancer types where LINC01370 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01370 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	Female	II,III,IV	−3.204	<.001	6	view →
STAD	All	All	−0.121	.007	6	view →
CHOL	All	All	−3.014	<.001	5	view →
LUSC	All	All	+0.150	.021	3	view →
THCA	All	All	+0.006	.025	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

LINC01370–LIHC

Open the LIHC breakdown →